Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in China, growing competitive threats, and the potential for Trump ...
Grail (GRAL) stock shot up 33% Thursday, the day after the company announced a partnership with Quest (DGX) to expand ...
CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024, emphasizing its strategic roadmap targeting high single-digit revenue growth by 2027. He noted significant advancements ...
BioLogic Pharma Solutions aims to be the trusted partner for companies handling complex drug development and commercialization pathways.
Regeneron, San Diego-based biotech company Illumina and 17 health systems invested in the $320 million round. Regeneron ...
The ECJ’s Illumina/Grail judgment has curtailed the ... create a fragmented tapestry of rules and timelines that heighten legal uncertainty. Although the ECJ ruling was meant to bring more ...
China has hit the US with retaliatory tariffs, possibly reigniting a trade war, while Trump has threatened further action ...
China swiftly imposed new tariffs on U.S. imports in response to President Trump's 10% tariff on Chinese goods, escalating ...
India Today on MSN9d
USPS halts China and Hong Kong package shipments amid US-China trade tensionsIn the latest escalation of rising tensions between the United States and China, the US Postal Service (USPS) has temporarily ...
Deel signals IPO preparations amid $300M funding and $12.6B valuation. Can the HR startup's public listing revive the quiet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback